Pulse nav.journalClub Aktive Debatten Trends Entdecken Forschende

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Start Entdecken nav.journalClub Trends

⌘+K

Brain PET in the Diagnosis of Alzheimer’s Disease | Synapse

September 5, 2014

Brain PET in the Diagnosis of Alzheimer’s Disease

Key Points

Key points are not available for this paper at this time.

Abstract

FDG-PET and amyloid PET imaging are valuable in the assessment of patients with Alzheimer's disease.

KI fragen

Like

Bookmark

Share

KI fragen

Like

Bookmark

Share

Cite This Study

Marcus et al. (Fri,) studied this question.

synapsesocial.com/papers/69da1a500d540cafc5838592 https://doi.org/https://doi.org/10.1097/rlu.0000000000000547

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment, and Early-Stage Alzheimer's Disease2001 · 515 citations
2Disease-modifying drugs in Alzheimer&#39;s disease2013 · 72 citations
3Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease2001 · 419 citations
4[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease2013 · 112 citations
5[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies2012 · 82 citations